Niagen Bioscience Increases Share Repurchase Program to $20 Million
Niagen Bioscience announced that its board of directors has authorized an increase to the company's previously disclosed share repurchase program, raising the total authorization from $10M to $20M of the company's outstanding common stock. Through March 17, the company has repurchased approximately $2.6M of its common stock under the share repurchase program.
